Posts by: Margarida Azevedo

Margarida Azevedo

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

January 24, 2019January 24, 2019

Rare Case of FUS, Tau Coexistence in Sporadic ALS Suggests Potential Biological Interaction

News

Tau and FUS proteins may contribute to a cellular process common to both amyotrophic lateral sclerosis (ALS) and dementia, a rare case suggests. The case was reported in a ... Read more

August 30, 2016

Neurotoxins in Shark Fins, Meat Linked to ALS and Other Neurodegenerative Diseases

News

University of Miami researchers found high concentrations of toxins associated with neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), in the fins and muscles of 10 different shark species, some ... Read more

August 25, 2016

Researchers Identify Culprit in ALS Nerve Cell Damage, Potentially Leading to New Therapies

News

Researchers at Harvard Medical School have made an important breakthrough in amyotrophic lateral sclerosis (ALS) research, identifying an enzyme that plays a key role in the demise of nerve ... Read more

August 23, 2016August 23, 2016

Cytokinetics Enrolls 700 ALS Patients in Phase 3 Study of Tirasemtiv

News

Cytokinetics recently announced that patient enrollment for its VITALITY-ALS clinical trial is now complete. The study, designed to assess the effects of tirasemtiv, a novel skeletal muscle activator, on respiratory function in ALS patients ... Read more

August 18, 2016August 18, 2016

Way of Preventing Harmful Protein Clumping Seen in ALS Raised in Early Study

News

Proteasome, a cellular component, plays a key role in the maintenance of proper levels of proteins inside cells. Two researchers at the Massachusetts General Hospital (MGH) have identified, through studies in ... Read more

July 28, 2016

Cytokinetics and ALS Association Expand Efforts to Improve ALS Treatment and Care

News

The ALS Association and the biopharmaceutical company Cytokinetics have announced the renewal and expansion of their partnership, established last year, to better treat amyotrophic lateral sclerosis (ALS) patients and educate the ... Read more

July 26, 2016

ALS Patients’ Quality of Life Impacted By Psychological Factors

News

Researchers at the University Medical Center Utrecht recently studied quality of life among people with amyotrophic lateral sclerosis (ALS) and found that anxiety and depression impact poorer health related quality of life ... Read more

July 22, 2016

ProMIS Neurosciences Targets Misfolded Protein in ALS Research Effort

News

ProMIS Neurosciences announced the start of a research program to identify new therapeutic targets on neurotoxic strains of a protein, TDP43, implicated in the development of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). TDP43 ... Read more

July 21, 2016

ALS Scientists Say Older Stem Cells Will Offer More Accurate Results as They Seek Treatments

News

Scientists at Cedars-Sinai Board of Governors Regenerative Medicine Institute who are researching methods for enhancing stem cell models for amyotrophic lateral sclerosis (ALS) have found that “aging” the cells could improve ... Read more

July 18, 2016

Researchers Find Autoimmune Role of Gene Central to ALS, Emphasize Need for Clinical Trials

News

Researchers at the Harvard Stem Cell Institute (HSCI), along with colleagues at the Broad Institute of MIT and Harvard, conducted a study focusing on the unexplored functions of a ... Read more

Pin It on Pinterest